ZMUni Compliance Centre

  On October 30, 2025, the China National Medical Products Administration (NMPA) approved two new registered cosmetic ingredients: one whitening agent and one colorant. These are the second and third ingredients approved under China's CSAR, following Beiersdorf's Thiamidol630 in November 2024.   Whitening Agent Dimethoxytolyl propylresorcinol (registration number: "国妆原注字20250002), was registered by Unigen Inc. Founded in 1996 and headquartered in Washington State, USA, Unigen Inc. is a company specializing in the research, development, and manufacture of natural active ingredients, with applications in dietary supplements, prescription drugs, and personal care products.   As announced by China NMPA, Dimethoxytolyl propylresorcinol has been registered as a whitening agent.

From October 25 to 31, 2025, 3 new cosmetic ingredients (NCIs) were notified with the China National Medical Products Administration (NMPA).    The technical requirements for the 3 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.   Bakuchiol Bakuchiol is a high-purity ingredient extracted and purified from crushed Psoralea corylifolia seeds to remove impurities and solvents. It functions as an antimicrobial, antioxidant, emollient, and skin-conditioning agent.   Since the first bakuchiol ingredient was notified in August 2022, a total of eight notificationns have been recorded to date. According to data from the China Association of Fragrance Flavor

From October 16 to 24, 2025, 4 new cosmetic ingredients (NCIs) were notified with the China National Medical Products Administration (NMPA).      The technical requirements for the 4 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.   Another noteworthy update is that on October 20, 2025, the NMPA released the second dynamic adjustment of the Inventory of Existing Cosmetic Ingredients in China (IECIC) this year, which involved the inclusion of three new cosmetic ingredients in the IECIC List II (bringing the total to five).   For details, please refer to our previous article: China Existing

      On October 20, 2025, China's National Institutes for Food and Drug Control (NIFDC) launched the first batch of new cosmetic ingreidents (NCIs) for innovation guidance. The selected NCIs were chosen based on four key criteria: first-to-market, Chinese characteristics, domestic substitution, and green low-carbon development.   This initiative aims to implement the Several Provisions on Supporting Cosmetic Ingredient Innovation and strengthen services for the innovation and application of new cosmetic ingredients.   Note: Being included in the innovation guidance list does not indicate that an ingredient's safety or quality has been approved. R&D must still comply with relevant regulations, and

    On October 20, 2025, China's National Medical Products Administration (NMPA) announced a three-year pilot program for electronic cosmetic labels, marking a significant step toward the digital transformation of cosmetic labeling in China. The pilot will begin on February 1, 2026, and will be implemented in Beijing, Shanghai, Zhejiang, Shandong, Guangdong, and Chongqing. The duty-free cosmetics pilot on Hainan Island, launched locally in September 2024, may also be carried out under the new NMPA requirements.   The pilot aims to optimize labeling management, enhance consumer access to product information, address the needs of elderly users, and facilitate business operations,

 On October 20, 2025, China's National Medical Products Administration (NMPA) has carried out the second dynamic update of the Inventory of Existing Cosmetic Ingredients in China (IECIC), following the first update earlier this year, which set the precedent for regular adjustments to ensure ingredient safety and regulatory compliance.   The updates to the inventory specifically includes:   List II of IECIC: 3 New Cosmetic Ingredients Included According to relevant regulations, new cosmetic ingredients (NCIs) that have completed a three-year safety monitoring period are reviewed by technical evaluation bodies. If deemed to meet safety requirements, they are officially included in List II of the IECIC.   Following the previous inclusion

Earlier this year, the Shanghai Medical Products Administration fined a foreign cosmetic registrant whose designated Domestic Responsible Person (DRP) failed to assist in adverse event monitoring and product recalls.    This case highlights a crucial reality for overseas brands entering China: the China RP is not just a formal contact — it is the legal "first responder" for compliance and product safety, bearing direct administrative liability under Chinese law. Understanding the obligations and risks associated with this role is essential for any foreign brand seeking a smooth and compliant entry into the Chinese market.   What Is a "Domestic Responsible Person" in China?

    On October 14,2025, China's National Institutes for Food and Drug Control (NIFDC) released 6 draft cosmetic standards for public consultation. These drafts include four test methods and two regulations, with the consultation period open until November 7, 2025.   The drafts are as follows: 1. 90-day Oral Toxicity Study 2. 90-day Dermal Toxicity Study 3. Bacterial Reverse Mutation Test 4. In Vitro Mammalian Cells Chromosome Aberration Test 5. General Principles of Cosmetic Product Standards 6. Technical Guidelines on the Intended Use of Cosmetic Ingredients